ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

1,4-ジヒドロ-1-メチル-4-オキソ-3-ピリジンカルボキサミド

1,4-Dihydro-1-methyl-4-oxo-3-pyridinecarboxamide

HCID 440810
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
769-49-3
標準SMILES
Cn1ccc(=O)c(C(N)=O)c1
InChIKey
KTLRWTOPTKGYQY-UHFFFAOYSA-N
分子式
C7H8N2O2
平均分子量
152.15 g/mol
単同位体質量
152.0585775

概要

N-methyl-4-pyridone-3-carboxamide is a member of the class of 4-pyridones that is 4-pyridone substituted with a carboxamide group at C-3 and a methyl group at N-1. It has a role as a mouse metabolite. It is a member of 4-pyridones, a member of methylpyridines and a pyridinecarboxamide.

名称と識別子

優先名称
1,4-Dihydro-1-methyl-4-oxo-3-pyridinecarboxamide
IUPAC
1-methyl-4-oxopyridine-3-carboxamide
現地名
1,4-ジヒドロ-1-メチル-4-オキソ-3-ピリジンカルボキサミド
英語名
1-methyl-4-oxo-pyridine-3-carboxamide
分子式
C7H8N2O2
分子量
152.15

名称と別名

769-49-31,4-Dihydro-1-methyl-4-oxo-3-pyridinecarboxamide1-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide1-Methyl-4-pyridone-3-carboximideN1-Methyl-4-pyridone-3-carboxamideN1-Methyl-4-pyridone-5-carboxamide1-Methyl-4-pyridone-5-carboxamide3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-4-oxo-1-Methyl-4-pyridone-3-carboxamideN'-Methyl-4-pyridone-5-carboxamideVE4S15CI8D1-Methyl-4-oxo-1,4-dihydro-3-pyridinecarboxamide
名称をさらに表示
1,4-ジヒドロ-1-メチル-4-オキソ-3-ピリジンカルボキサミド1-メチル-3-カルバモイル-4-ピリドン1-メチル-4-オキソ-1,4-ジヒドロピリジン-3-カルボキサミドN-Methyl-4-pyridone-5-carboxamide1-methyl-4-oxo-pyridine-3-carboxamide1,4-Dihydro-1-methyl-4-oxonicotinamideN-Methyl-4-pyridone-5-carboxamide1-Methyl-4-oxo-1,4-dihydro-pyridine-3-carboxylic acid amide
5-Aminocarbonyl-1-methyl-4(1H)-pyridone3-(Aminocarbonyl)-1-methyl-4(1H)-pyridoneDTXSID80227697NICOTINAMIDE, 1,4-DIHYDRO-1-METHYL-4-OXO-RefChem:416775DTXCID30150188845-640-9n-methyl-4-pyridone-3-carboxamide

物性

構造計算による物性

XLogP
-0.1
極性表面積
63.4 Ų
水素結合供与体数
1
水素結合受容体数
3
回転可能結合数
1
重原子数
11
形式電荷
0
複雑度
266

実験および物理化学的性質

Physical DescriptionSolid

物理化学的性質

融点
179 · 179-181 °C
沸点
350.6 · 350.6±42.0 °C(Predicted)
比重(密度)
1.3 · 1.300±0.06 g/cm3(Predicted)
貯蔵温度
-20 °C · -20°C
溶解性
Ethanol: Slightly soluble,PBS (pH 7.2): 5 mg/ml
外見
A solid
酸解離定数(Pka)
13.14 · 13.14±0.20(Predicted)
色
White to off-white
InChI
InChI=1S/C7H8N2O2/c1-9-3-2-6(10)5(4-9)7(8)11/h2-4H,1H3,(H2,8,11)
InChIKey
KTLRWTOPTKGYQY-UHFFFAOYSA-N
SMILES
C1N(C)C=CC(=O)C=1C(N)=O

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 件

Uremic toxins such as N-methyl-4-pyridone-3-carboxamide are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

化学と産業

薬理情報

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
Cellular LocationsCytoplasm
Metabolite PathwaysNicotinate and nicotinamide metabolism

用途と製造

UsesNaturally produced by the body (endogenous).

応用分野

使用1,4-Dihydro-1-methyl-4-oxo-3-pyridinecarboxamide, has been shown to be one of the potential novel biomarkers of peroxisome proliferation in the rat.

サプライヤー41 社

武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
苏州申拓医药科技有限公司13911244683 18151949202 · [email protected]
武汉敬康恩生物医药科技有限公司13720134139 086-15871494362 13720134139 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
咸宁深蓝生物医药研发有限公司18171815831 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
769-49-3
PubChem CID
440810
DTXSID
DTXSID80227697
ChEMBL
CHEMBL3542326
ChEBI
CHEBI:27838
UNII
VE4S15CI8D
EC Number
845-640-9
Nikkaji
J367.452E
Signs and Symptoms · 1 件

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

安全データ

wgk
WGK 3
ストレージクラス
11 - Combustible Solids
云南西力生物技术股份有限公司
0871-65217109 · [email protected]
南京世洲生物科技有限公司025-025-85560043 17301488900 · [email protected]
上海赛可锐生物科技有限公司021-58000709 13120558703 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
上海瀚香生物科技有限公司177-54423994 17754423994 · [email protected]
NANJING YINGWEN BIOTECHNOLOGY CO LTD+8613382787392 · [email protected]
常州布克化工有限公司13606129753 13775119556 · [email protected]
玺标(上海)科技有限公司18512111473 18512111473 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
Cato Research Chemicals Inc.020-81960175 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
BOC Sciences16314854226 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
湖北昭亿生物科技有限公司13437178871 · [email protected]
郑州汇聚化工有限公司0371-55900031 18137872243 · [email protected]
上海瀚香生物科技有限公司17754423994 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 17714375163 · [email protected]
长沙福臻生物科技有限公司15111215862 18229892877 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
南京康满林化工实业有限公司025-83697070 13770331960 · [email protected]
上海莫奇生物科技有限公司13341702378 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
上海智溯科生物科技有限公司021-58056897 15399714481 · [email protected]
上海传芊化工科技中心15869524721 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
南京世洲生物科技有限公司18351873721 · [email protected]
河南伊诺凯新材料有限公司15090072163 · [email protected]
上海宾穗生物科技有限公司18301908279 · [email protected]

補足説明

定義ChEBI: A member of the class of 4-pyridones that is 4-pyridone substituted with a carboxamide group at C-3 and a methyl group at N-1.